Bausch Health Companies (BHC) Interest & Investment Income (2009 - 2026)
Bausch Health Companies (BHC) reported Interest & Investment Income of $10.0 million for Q1 2026, down 9.09% on a YoY basis from $11.0 million in Q1 2025, and up 11.11% sequentially from $9.0 million in Q4 2025.
Bausch Health Companies (BHC) Interest & Investment Income (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Interest & Investment Income data on file, last reported at $10.0 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 9.09% year-over-year to $10.0 million; the trailing twelve-month figure through Mar 2026 stood at $47.0 million (up 34.29% YoY), and the FY2025 full-year result was $48.0 million, up 45.45% from the prior year.
- Interest & Investment Income advanced to $10.0 million in Q1 2026, from $9.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $15.0 million in Q3 2025 to a low of $2.0 million in Q1 2022.
- A 5-year average of $7.7 million and a median of $7.0 million in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 500.0% in 2022 and decreased 9.09% in 2026, its largest moves.
- Tracing BHC's Interest & Investment Income over 5 years: stood at $6.0 million in 2022, then climbed by 16.67% to $7.0 million in 2023, then grew by 28.57% to $9.0 million in 2024, then changed by 0.0% to $9.0 million in 2025, then climbed by 11.11% to $10.0 million in 2026.
- Business Quant data shows BHC's Interest & Investment Income at $10.0 million in Q1 2026, $9.0 million in Q4 2025, and $15.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.68 Bn | 367.46 Mn | 2.52 Bn | 10.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.00 Mn |
| Dec 31, 2025 | 9.00 Mn |
| Sep 30, 2025 | 15.00 Mn |
| Jun 30, 2025 | 13.00 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Dec 31, 2024 | 9.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 8.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | 7.00 Mn |
| Sep 30, 2023 | 6.00 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 6.00 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 2.00 Mn |